D&O Initial Disclosure

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
20 January 2023
Date on which issuer listed or appointment made:
16 January 2023
Director or senior manager giving disclosure
Full name:
Denice Mary Bennett
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Financial Officer
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares.
Number held in class:
25,000 unlisted employee options to
purchase 25,000 ordinary shares.
Nature of relevant interest:
The 25,000 Options will be issued on 1 April
2023 at an exercise price of $2 per share.
The options vest in three tranches of 5,000
options, 7,500 options and 12,500 options.
Vesting is subject to continued employment
and achievement of agreed performance
targets achieved by 31 March 2026, 31
March 2027 and 31 March 2028. Any
Ordinary Shares in Third Age Health Services
Limited issued on the exercise of the Options
will rank equally in all respects with all other
Ordinary Shares on issue in Third Age Health
Services Limited.
Current registered holder:
Denice Mary Bennett
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
N/A
Class of underlying financial products:
N/A
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative (if any):
N/A
The price specified in the terms of the derivative(if any):
N/A
Any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the value
of the underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A

If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in
this disclosure is correct and that I am duly authorised to make this disclosure by
all persons for whom it is made.
Signature of director or officer:
Date of signature:
20 January 2023